Surgical Management of Malignant Intestinal Obstruction: Outcome and Prognostic Factors

Imagem de Miniatura
Arquivos
art_SOUSA_Surgical_Management_of_Malignant_Intestinal_Obstruction_Outcome_and_2019.PDF (396.23 KB)
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
EDITURA CELSIUS
Autores
Citação
CHIRURGIA, v.114, n.3, p.343-351, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background:Malignant intestinal obstruction is a frequent complication in advanced stages cancer patients. The prognosis is poor, with mean survival rate beneath 3 months. Clinical treatment, endoscopic or surgical procedures are options for malignant intestinal obstruction management. There is no generally accepted management strategy. Objectives: To evaluate prognostic factors of patients with malignant intestinal obstruction who underwent surgical treatment. Methods: A retrospective analysis was performed including patients of a single institution with diagnosis of malignant intestinal obstruction. Demographic data, in-hospital stay, postoperative complications, and overall survival were assessed. Logistic regression was used to evaluate associated prognostic factors. Results: Two hundred thirty-three surgeries were performed due to suspicion for malignant intestinal obstruction over a seven-year period. This diagnosis was confirmed in 210 operations (90.1%). The main causes of malignant obstruction were colorectal (49.5%) and gynecological cancer (21.9%). The rate of severe complications was 11.42%. In-hospital mortality rate was 40.95% (CI 95%: 34.16-47.74%). Functional status impairment,high serum urea, and low albumin levels were associated to higher mortality rate. Conclusion: Malignant intestinal obstruction implies poor prognosis, with high in-hospital mortality rate and severe postoperative complications. The decision regarding management of malignant intestinal obstruction must be multimodal and individualized, according to individual prognostic factors.
Palavras-chave
intestinal obstruction, ascitic fluid, peritoneal neoplasms, palliative care
URI
https://observatorio.fm.usp.br/handle/OPI/33489
Referências
  1. Abbas Saleh M, 2007, World J Surg Oncol, V5, P122, DOI 10.1186/1477-7819-5-122
  2. Abbas SM, 2006, INT J CANC RES, V2, P42, DOI 10.3923/IJCR.2006.42.46
  3. Anthony T, 2007, J PAIN SYMPTOM MANAG, V34, pS49, DOI 10.1016/j.jpainsymman.2007.04.011
  4. BAIS JMJ, 1995, INT J GYNECOL CANCER, V5, P346, DOI 10.1046/j.1525-1438.1995.05050346.x
  5. Blair SL, 2001, ANN SURG ONCOL, V8, P632, DOI 10.1007/s10434-001-0632-1
  6. Bryan DN, 2006, INT J GYNECOL CANCER, V16, P125, DOI 10.1111/j.1525-1438.2006.00283.x
  7. Chakraborty A, 2011, J PAIN SYMPTOM MANAG, V41, P412, DOI 10.1016/j.jpainsymman.2010.05.007
  8. Chi DS, 2009, ONCOLOGIST, V14, P835, DOI 10.1634/theoncologist.2009-0057
  9. Cousins SE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002764.pub2
  10. Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
  11. Feuer DJ, 1999, GYNECOL ONCOL, V75, P313, DOI 10.1006/gyno.1999.5594
  12. Helyer Lucy, 2008, J Support Oncol, V6, P105
  13. Henry JC, 2012, SURGERY, V152, P747, DOI 10.1016/j.surg.2012.07.009
  14. JACQUET P, 1993, CANCER, V72, P1631, DOI 10.1002/1097-0142(19930901)72:5<1631::AID-CNCR2820720523>3.0.CO;2-I
  15. JONG P, 1995, CAN J SURG, V38, P454
  16. Kolomainen DF, 2012, GYNECOL ONCOL, V125, P31, DOI 10.1016/j.ygyno.2011.11.007
  17. KROUSE RS, 2007, J PAIN SYMPTOM MAN S, V34, pS
  18. LAU PWK, 1993, DIS COLON RECTUM, V36, P61, DOI 10.1007/BF02050303
  19. LUND B, 1989, SURG GYNECOL OBSTET, V169, P213
  20. Mangili G, 2005, INT J GYNECOL CANCER, V15, P830, DOI 10.1111/j.1525-1438.2005.00144.x
  21. MCCARTHY JD, 1986, ARCH SURG-CHICAGO, V121, P1081
  22. Mirensky TL, 2012, AM J SURG, V203, P472, DOI 10.1016/j.amjsurg.2011.07.013
  23. Parker MC, 1996, BRIT J SURG, V83, P1, DOI 10.1002/bjs.1800830102
  24. PIVER MS, 1982, GYNECOL ONCOL, V13, P44, DOI 10.1016/0090-8258(82)90007-5
  25. Pothuri B, 2003, GYNECOL ONCOL, V89, P306, DOI 10.1016/S0090-8258(03)00073-8
  26. Ripamonti C, 2001, SUPPORT CARE CANCER, V9, P223, DOI 10.1007/s005200000198
  27. Romeo M, 2016, SUPPORT CARE CANCER, V24, P4577, DOI 10.1007/s00520-016-3299-7
  28. RUBIN SC, 1989, GYNECOL ONCOL, V34, P16, DOI 10.1016/0090-8258(89)90097-8
  29. Selby D, 2010, PALLIATIVE MED, V24, P38, DOI 10.1177/0269216309346544
  30. Tuca Albert, 2012, Cancer Manag Res, V4, P159, DOI 10.2147/CMAR.S29297
  31. TUNCA JC, 1981, GYNECOL ONCOL, V12, P186, DOI 10.1016/0090-8258(81)90148-7
  32. TURNBULL ADM, 1989, J CLIN ONCOL, V7, P381, DOI 10.1200/JCO.1989.7.3.381

Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - LIM/35
Artigos e Materiais de Revistas Científicas - ODS/03